Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruiheng Wang

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|December 12, 2019
Arsenic sulfide induces RAG1-dependent DNA damage for cell killing by inhibiting NFATc3 in gastric cancer cellsTing Kang, Maolin Ge, Ruiheng Wang, et al.
Biochemical Pharmacology|July 13, 2025
Rhein suppresses osteosarcoma progression via modulating the miR-328-3p/TCF7L2/FABP4 axisXin Zhao, Ruiheng Wang, Xin Xia, et al.
Cellular & Molecular Biology Letters|August 15, 2025
Palmitoylation: an emerging therapeutic target bridging physiology and diseaseWeini Li, Jie Shen, Aojia Zhuang, et al.
FEBS Letters|November 29, 2020
mTORC1-mediated amino acid signaling is critical for cell fate determination under transplant-induced stressXiaoyan Cheng, Maolin Ge, Shouhai Zhu, et al.
Cancer Science|March 19, 2021
Deubiquitinating enzyme inhibitor alleviates cyclin A1-mediated proteasome inhibitor tolerance in mixed-lineage leukemiaMaolin Ge, Qiongyu Xu, Ting Kang, et al.
Theranostics|February 14, 2022
A T-cell independent universal cellular therapy strategy through antigen depletionDan Li, Wenbing Wang, Shufeng Xie, et al.
Frontiers in Immunology|September 29, 2025
Arsenic sulfide enhances the therapeutic effect of hepatocellular carcinoma immunotherapy through STAT3-THBS1/CD47 pathwayTing Kang, Zhuowei Feng, Yu Cai, et al.
Biomaterials Science|April 8, 2022
Multifunctional theranostic nanoparticles for multi-modal imaging-guided CAR-T immunotherapy and chemo-photothermal combinational therapy of non-Hodgkin's lymphomaBowen Shi, Dan Li, Weiwu Yao, et al.
Cell Death Discovery|April 9, 2022
Targeting matrix metallopeptidase 2 by hydroxyurea selectively kills acute myeloid mixed-lineage leukemiaRuiheng Wang, Shufeng Xie, Shouhai Zhu, et al.
Molecules (Basel, Switzerland)|November 27, 2024
Cannabigerol (CBG): A Comprehensive Review of Its Molecular Mechanisms and Therapeutic PotentialShijia Li, Weini Li, Naseeb Kaur Malhi, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Journal of Experimental & Clinical Cancer Research : CR|December 12, 2019
Arsenic sulfide induces RAG1-dependent DNA damage for cell killing by inhibiting NFATc3 in gastric cancer cellsTing Kang, Maolin Ge, Ruiheng Wang, et al.
Biochemical Pharmacology|July 13, 2025
Rhein suppresses osteosarcoma progression via modulating the miR-328-3p/TCF7L2/FABP4 axisXin Zhao, Ruiheng Wang, Xin Xia, et al.
Cellular & Molecular Biology Letters|August 15, 2025
Palmitoylation: an emerging therapeutic target bridging physiology and diseaseWeini Li, Jie Shen, Aojia Zhuang, et al.
FEBS Letters|November 29, 2020
mTORC1-mediated amino acid signaling is critical for cell fate determination under transplant-induced stressXiaoyan Cheng, Maolin Ge, Shouhai Zhu, et al.
Cancer Science|March 19, 2021
Deubiquitinating enzyme inhibitor alleviates cyclin A1-mediated proteasome inhibitor tolerance in mixed-lineage leukemiaMaolin Ge, Qiongyu Xu, Ting Kang, et al.
Theranostics|February 14, 2022
A T-cell independent universal cellular therapy strategy through antigen depletionDan Li, Wenbing Wang, Shufeng Xie, et al.
Frontiers in Immunology|September 29, 2025
Arsenic sulfide enhances the therapeutic effect of hepatocellular carcinoma immunotherapy through STAT3-THBS1/CD47 pathwayTing Kang, Zhuowei Feng, Yu Cai, et al.
Biomaterials Science|April 8, 2022
Multifunctional theranostic nanoparticles for multi-modal imaging-guided CAR-T immunotherapy and chemo-photothermal combinational therapy of non-Hodgkin's lymphomaBowen Shi, Dan Li, Weiwu Yao, et al.
Cell Death Discovery|April 9, 2022
Targeting matrix metallopeptidase 2 by hydroxyurea selectively kills acute myeloid mixed-lineage leukemiaRuiheng Wang, Shufeng Xie, Shouhai Zhu, et al.
Molecules (Basel, Switzerland)|November 27, 2024
Cannabigerol (CBG): A Comprehensive Review of Its Molecular Mechanisms and Therapeutic PotentialShijia Li, Weini Li, Naseeb Kaur Malhi, et al.
Pageof 4